PubMed:7727787
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 116-127 | gene:3050 | denotes | zeta-globin |
| T1 | 272-287 | disease:C0023440 | denotes | erythroleukemia |
| T2 | 167-178 | gene:3050 | denotes | zeta-globin |
| T3 | 272-287 | disease:C0023440 | denotes | erythroleukemia |
| R1 | T0 | T1 | associated_with | zeta-globin,erythroleukemia |
| R2 | T2 | T3 | associated_with | zeta-globin,erythroleukemia |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-53 | DNA | denotes | positive regulatory element |
| T2 | 72-94 | DNA | denotes | human zeta-globin gene |
| T3 | 116-136 | DNA | denotes | zeta-globin promoter |
| T4 | 167-207 | DNA | denotes | zeta-globin promoter deletion constructs |
| T5 | 217-227 | protein | denotes | luciferase |
| T6 | 242-293 | cell_line | denotes | transiently transfected human erythroleukemia cells |
| T7 | 299-308 | DNA | denotes | promoters |
| T8 | 327-336 | DNA | denotes | enhancers |
| T9 | 346-355 | DNA | denotes | enhancers |
| T10 | 373-405 | DNA | denotes | beta-globin locus control region |
| T11 | 414-441 | DNA | denotes | alpha-globin HS-40 enhancer |
| T12 | 465-475 | cell_line | denotes | K562 cells |
| T13 | 491-502 | protein | denotes | zeta-globin |
| T14 | 558-598 | DNA | denotes | -557 and -417 zeta-luciferase constructs |
| T15 | 607-634 | DNA | denotes | alpha-luciferase constructs |
| T16 | 643-652 | DNA | denotes | enhancers |
| T17 | 660-688 | DNA | denotes | alpha-globin locus enhancers |
| T18 | 742-753 | cell_line | denotes | OCIM1 cells |
| T19 | 776-787 | protein | denotes | zeta-globin |
| T20 | 793-814 | DNA | denotes | zeta-globin promoters |
| T21 | 849-871 | DNA | denotes | alpha-globin promoters |
| T22 | 878-908 | DNA | denotes | sequences from -417 to -207 5' |
| T23 | 916-941 | RNA | denotes | zeta-globin mRNA cap site |
| T24 | 973-993 | DNA | denotes | zeta-globin promoter |
| T25 | 1015-1025 | cell_line | denotes | K562 cells |
| T26 | 1063-1089 | DNA | denotes | zeta-luciferase constructs |
| T27 | 1202-1213 | DNA | denotes | GATA-1 site |
| T28 | 1276-1286 | DNA | denotes | CCACC site |
| T29 | 1367-1383 | DNA | denotes | -230 GATA-1 site |
| T30 | 1418-1424 | protein | denotes | GATA-1 |
| T31 | 1474-1497 | DNA | denotes | positive-acting element |
| T32 | 1515-1534 | DNA | denotes | -417 and -207 bp 5' |
| T33 | 1542-1567 | DNA | denotes | zeta-globin mRNA cap site |
| T34 | 1618-1628 | cell_line | denotes | K562 cells |
| T35 | 1652-1658 | protein | denotes | GATA-1 |
| T36 | 1663-1689 | protein | denotes | additional unknown factors |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 7727787-1#20#31#gene3050 | 116-127 | gene3050 | denotes | zeta-globin |
| 7727787-1#71#82#gene3050 | 167-178 | gene3050 | denotes | zeta-globin |
| 7727787-1#176#191#diseaseC0023440 | 272-287 | diseaseC0023440 | denotes | erythroleukemia |
| 20#31#gene3050176#191#diseaseC0023440 | 7727787-1#20#31#gene3050 | 7727787-1#176#191#diseaseC0023440 | associated_with | zeta-globin,erythroleukemia |
| 71#82#gene3050176#191#diseaseC0023440 | 7727787-1#71#82#gene3050 | 7727787-1#176#191#diseaseC0023440 | associated_with | zeta-globin,erythroleukemia |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 68-94 | NP | denotes | the human zeta-globin gene |
| C2 | 112-136 | NP | denotes | the zeta-globin promoter |
| C3 | 155-207 | NP | denotes | a series of zeta-globin promoter deletion constructs |
| C4 | 295-308 | NP | denotes | The promoters |
| C5 | 465-475 | NP | denotes | K562 cells |
| C6 | 477-482 | NP | denotes | which |
| C7 | 491-502 | NP | denotes | zeta-globin |
| C8 | 549-634 | NP | denotes | from the -557 and -417 zeta-luciferase constructs and the alpha-luciferase constructs |
| C9 | 705-719 | NP | denotes | the constructs |
| C10 | 742-753 | NP | denotes | OCIM1 cells |
| C11 | 755-760 | NP | denotes | which |
| C12 | 776-787 | NP | denotes | zeta-globin |
| C13 | 789-814 | NP | denotes | the zeta-globin promoters |
| C15 | 893-941 | NP | denotes | -417 to -207 5' to the zeta-globin mRNA cap site |
| C14 | 878-941 | NP | denotes | sequences from -417 to -207 5' to the zeta-globin mRNA cap site |
| C16 | 1015-1025 | NP | denotes | K562 cells |
| C17 | 1042-1057 | NP | denotes | these sequences |
| C18 | 1134-1147 | NP | denotes | the sequences |
| C19 | 1200-1221 | NP | denotes | a GATA-1 site at -230 |
| C20 | 1363-1383 | NP | denotes | the -230 GATA-1 site |
| C21 | 1418-1424 | NP | denotes | GATA-1 |
| C22 | 1515-1567 | NP | denotes | -417 and -207 bp 5' to the zeta-globin mRNA cap site |
| C23 | 1618-1628 | NP | denotes | K562 cells |
| C24 | 1652-1658 | NP | denotes | GATA-1 |
| R1 | C4 | C3 | coref-ident | The promoters,a series of zeta-globin promoter deletion constructs |
| R2 | C6 | C5 | coref-relat | which,K562 cells |
| R3 | C7 | C1 | coref-ident | zeta-globin,the human zeta-globin gene |
| R4 | C9 | C8 | coref-ident | the constructs,from the -557 and -417 zeta-luciferase constructs and the alpha-luciferase constructs |
| R5 | C11 | C10 | coref-relat | which,OCIM1 cells |
| R6 | C12 | C7 | coref-ident | zeta-globin,zeta-globin |
| R7 | C13 | C2 | coref-ident | the zeta-globin promoters,the zeta-globin promoter |
| R8 | C16 | C5 | coref-ident | K562 cells,K562 cells |
| R9 | C17 | C14 | coref-ident | these sequences,sequences from -417 to -207 5' to the zeta-globin mRNA cap site |
| R10 | C18 | C17 | coref-ident | the sequences,these sequences |
| R11 | C20 | C19 | coref-ident | the -230 GATA-1 site,a GATA-1 site at -230 |
| R12 | C22 | C15 | coref-ident | -417 and -207 bp 5' to the zeta-globin mRNA cap site,-417 to -207 5' to the zeta-globin mRNA cap site |
| R13 | C23 | C16 | coref-ident | K562 cells,K562 cells |
| R14 | C24 | C21 | coref-ident | GATA-1,GATA-1 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-95 | Sentence | denotes | Identification of a major positive regulatory element located 5' to the human zeta-globin gene. |
| S2 | 96-294 | Sentence | denotes | The function of the zeta-globin promoter was studied using a series of zeta-globin promoter deletion constructs to drive luciferase expression in transiently transfected human erythroleukemia cells. |
| S3 | 295-442 | Sentence | denotes | The promoters were used without enhancers, or with enhancers derived from the beta-globin locus control region and the alpha-globin HS-40 enhancer. |
| S4 | 443-699 | Sentence | denotes | When transfected into K562 cells, which express zeta-globin, comparable amounts of activity were obtained from the -557 and -417 zeta-luciferase constructs and the alpha-luciferase constructs when no enhancers or the alpha-globin locus enhancers were used. |
| S5 | 700-872 | Sentence | denotes | When the constructs were transfected into OCIM1 cells, which do not express zeta-globin, the zeta-globin promoters were at best 20% as active as the alpha-globin promoters. |
| S6 | 873-1026 | Sentence | denotes | When sequences from -417 to -207 5' to the zeta-globin mRNA cap site were deleted, up to 95% of the zeta-globin promoter activity was lost in K562 cells. |
| S7 | 1027-1181 | Sentence | denotes | Reinsertion of these sequences into zeta-luciferase constructs missing the -417 to -207 region showed that the sequences lack classical enhancer activity. |
| S8 | 1182-1255 | Sentence | denotes | Point mutation of a GATA-1 site at -230 reduced promoter activity by 37%. |
| S9 | 1256-1309 | Sentence | denotes | Point mutation of a CCACC site at -240 had no effect. |
| S10 | 1310-1425 | Sentence | denotes | Electrophoretic mobility shift assays indicated that the -230 GATA-1 site has a relatively low affinity for GATA-1. |
| S11 | 1426-1629 | Sentence | denotes | These experiments show the presence of a strong positive-acting element, located between -417 and -207 bp 5' to the zeta-globin mRNA cap site, is necessary for high-level promoter activity in K562 cells. |
| S12 | 1630-1711 | Sentence | denotes | This element requires GATA-1 and additional unknown factors for maximal activity. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-53 | DNA_family_or_group | denotes | positive regulatory element |
| T2 | 72-94 | DNA_domain_or_region | denotes | human zeta-globin gene |
| T3 | 116-136 | DNA_domain_or_region | denotes | zeta-globin promoter |
| T4 | 167-187 | DNA_domain_or_region | denotes | zeta-globin promoter |
| T5 | 217-227 | protein_molecule | denotes | luciferase |
| T6 | 242-293 | cell_line | denotes | transiently transfected human erythroleukemia cells |
| T7 | 299-308 | DNA_family_or_group | denotes | promoters |
| T8 | 327-336 | DNA_family_or_group | denotes | enhancers |
| T9 | 346-355 | DNA_family_or_group | denotes | enhancers |
| T10 | 373-405 | DNA_domain_or_region | denotes | beta-globin locus control region |
| T11 | 414-441 | DNA_domain_or_region | denotes | alpha-globin HS-40 enhancer |
| T12 | 465-475 | cell_line | denotes | K562 cells |
| T13 | 491-502 | protein_family_or_group | denotes | zeta-globin |
| T14 | 558-577 | DNA_molecule | denotes | -557 and -417 zeta- |
| T15 | 577-587 | protein_molecule | denotes | luciferase |
| T16 | 607-613 | DNA_molecule | denotes | alpha- |
| T17 | 613-623 | protein_molecule | denotes | luciferase |
| T18 | 643-652 | DNA_family_or_group | denotes | enhancers |
| T19 | 660-678 | DNA_domain_or_region | denotes | alpha-globin locus |
| T20 | 679-688 | DNA_family_or_group | denotes | enhancers |
| T21 | 742-753 | cell_line | denotes | OCIM1 cells |
| T22 | 776-787 | protein_family_or_group | denotes | zeta-globin |
| T23 | 793-804 | protein_family_or_group | denotes | zeta-globin |
| T24 | 849-861 | DNA_family_or_group | denotes | alpha-globin |
| T25 | 862-871 | DNA_family_or_group | denotes | promoters |
| T26 | 878-908 | DNA_domain_or_region | denotes | sequences from -417 to -207 5' |
| T27 | 916-932 | RNA_molecule | denotes | zeta-globin mRNA |
| T28 | 973-984 | protein_family_or_group | denotes | zeta-globin |
| T29 | 1015-1025 | cell_line | denotes | K562 cells |
| T30 | 1063-1068 | DNA_family_or_group | denotes | zeta- |
| T31 | 1068-1078 | protein_molecule | denotes | luciferase |
| T32 | 1153-1180 | other_name | denotes | classical enhancer activity |
| T33 | 1182-1196 | other_name | denotes | Point mutation |
| T34 | 1202-1208 | protein_molecule | denotes | GATA-1 |
| T35 | 1230-1247 | other_name | denotes | promoter activity |
| T36 | 1256-1270 | other_name | denotes | Point mutation |
| T37 | 1276-1286 | DNA_domain_or_region | denotes | CCACC site |
| T38 | 1310-1347 | other_name | denotes | Electrophoretic mobility shift assays |
| T39 | 1367-1371 | DNA_domain_or_region | denotes | -230 |
| T40 | 1372-1378 | protein_molecule | denotes | GATA-1 |
| T41 | 1418-1424 | protein_molecule | denotes | GATA-1 |
| T42 | 1474-1497 | DNA_domain_or_region | denotes | positive-acting element |
| T43 | 1515-1534 | DNA_domain_or_region | denotes | -417 and -207 bp 5' |
| T44 | 1542-1553 | protein_family_or_group | denotes | zeta-globin |
| T45 | 1586-1614 | other_name | denotes | high-level promoter activity |
| T46 | 1618-1628 | cell_line | denotes | K562 cells |
| T47 | 1652-1658 | protein_molecule | denotes | GATA-1 |
| T48 | 1663-1689 | protein_family_or_group | denotes | additional unknown factors |
| T49 | 1694-1710 | other_name | denotes | maximal activity |